Binding modes of peptidomimetics designed to inhibit STAT3.
STAT3 is a transcription factor that has been found to be constitutively activated in a number of human cancers. Dimerization of STAT3 via its SH2 domain and the subsequent translocation of the dimer to the nucleus leads to transcription of anti-apoptotic genes. Prevention of the dimerization is thu...
Main Authors: | Ankur Dhanik, John S McMurray, Lydia E Kavraki |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23251591/pdf/?tool=EBI |
Similar Items
-
Silencing of STAT3 via Peptidomimetic LNP-Mediated Systemic Delivery of RNAi Downregulates PD-L1 and Inhibits Melanoma Growth
by: Ehexige Ehexige, et al.
Published: (2020-02-01) -
Design and synthesis of novel sila-peptidomimetics
by: McArthur, Duncan Robert
Published: (2002) -
Design and Synthesis of Bioactive Peptidomimetics
by: Hu, Yaogang
Published: (2015) -
Design and synthesis of peptidomimetic scaffolds
by: Huot, Mitchell
Published: (2010) -
Computational approaches to peptidomimetic design
by: Wynn, Hamish Henry
Published: (2001)